Although it’s unlikely we’ll ever see Brock Lesnar back in the Octagon at this point, he’s been temporarily suspended, pending a full hearing over failed drug tests surrounding his UFC 200 fight.
On Tuesday (Aug. 23), the Nevada State Athletic Commission (NSAC) revealed during a hearing that Lesnar tested positive for clomiphene and hydroxy-clomiphene, a metabolite of chomiphene. And, Clomiphene is an anti-estrogen agent that is typically used after a cycle of steroids to prevent the many side effects that come along with the performance-enhancing drug.
Leading up to his UFC 200 return, Lesnar failed two drug tests — one from a pre-fight out of competition sample on June 28 and another from the night of his fight with Mark Hunt on July 9.
During the fight, he won via unanimous decision, but the state of Nevada has the right to overturn the result, depending on the outcome of his hearing.
He now faces potential sanctions from both Nevada and USADA (United States Anti-Doping Agency), who oversees the UFC’s drug testing program.
Since the news surfaced, Lesnar received a huge amount of backlash from Hunt, who has called for the UFC to pay him the $2.5 million Brock made for the fight.
The date for Lesnar’s next hearing will be determined soon…